Guideline-directed medical therapy

Dixit NM, Parikh NU, Ziaeian B, Jackson N, Fonarow GC. Cost-Effectiveness of Comprehensive Quadruple Therapy for Heart Failure With Reduced Ejection Fraction. JACC Heart Fail. 2023[...]

Harrington J, Fonarow GC, Khan MS, Hernandez A, Anker S, Böhm M, Greene SJ, Felker GM, Vaduganathan M, Butler J. Medication-Attributable Adverse Events in Heart Failure Trials.[...]

Kanda E, Rastogi A, Murohara T, Lesén E, Agiro A, Arnold M, Chen G, Yajima T, Järbrink K, Pollack CV Jr. Clinical impact of suboptimal[...]

Dixit NM, Ziaeian B, Fonarow GC. SGLT2 Inhibitors in Heart Failure: Early Initiation to Achieve Rapid Clinical Benefits. Heart Fail Clin. 2022 Oct;18(4):587-596. doi: 10.1016/j.hfc.2022.03.003.[...]

Granger BB, Kaltenbach LA, Fonarow GC, Allen LA, Lanfear DE, Albert NM, Al-Khalidi HR, Butler J, Cooper LB, Dewald T, Felker GM, Heidenreich P, Kottam[...]